ARIX BIOSCIENCE PLC

Profile

Company Names

ARIX BIOSCIENCE PLC

Addresses

20 BERKELEY SQUARE, LONDON, X0 W1J 6EQ

Phone Numbers

44(0)20 7290 1050

 

Entity Type:

OTHER

Industry:

OTHER HEALTH CARE

Year Incorporated:

2015

State Incorporated:

UNITED KINGDOM

Total Amount Raised:

$39,382,321.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2018-03-20 
$21,438,354.00 
$121,778,626.00 
$100,340,272.00 
Equity 
1
2017-02-22 
$17,943,967.00 
$124,560,000.00 
$106,616,033.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOSEPH 
 
ANDERSON 
EXECUTIVE OFFICER, DIRECTOR
AMARIN CORP PLC\UK   |  PACIFIC NORTHWEST CAPITAL CORP.   |  ARIX BIOSCIENCE PLC   |  AUTOLUS THERAPEUTICS PLC   |  WORKING FIELDS VERMONT, INC.
JOHN 
 
BANHAM 
DIRECTOR
CYCLACEL PHARMACEUTICALS, INC.   |  ARIX BIOSCIENCE PLC
CHRISTOPHER 
 
EVANS 
EXECUTIVE OFFICER, DIRECTOR
ARIX BIOSCIENCE PLC   |  TETHIS, INC.   |  NEXT CENTURY SPIRITS, INC
MEGHAN 
MAIR 
FITZGERALD 
DIRECTOR
ARIX BIOSCIENCE PLC
FRANZ 
 
HUMER 
DIRECTOR
ARIX BIOSCIENCE PLC   |  ALLOGENE THERAPEUTICS, INC.   |  NEOGENE THERAPEUTICS, INC.
JOHN 
 
HUTTON OF FURNESS 
DIRECTOR
ARIX BIOSCIENCE PLC
TREVOR 
 
JONES 
DIRECTOR
NANOSCALE CORP   |  ARIX BIOSCIENCE PLC   |  LYNX GLOBAL INTELLIGENCE, INC.
GILES 
 
KERR 
DIRECTOR
BTG PLC   |  SENIOR PLC   |  ARIX BIOSCIENCE PLC
JOHN 
 
MUTTON OF FURNESS 
DIRECTOR
ARIX BIOSCIENCE PLC
JONATHAN 
 
PEACOCK 
EXECUTIVE OFFICER, DIRECTOR
AMGEN INC   |  BELLEROPHON THERAPEUTICS LLC   |  ARIX BIOSCIENCE PLC   |  BELLEROPHON THERAPEUTICS, INC.
JAMES 
 
RAWLINGSON 
EXECUTIVE OFFICER, DIRECTOR
ARIX BIOSCIENCE PLC
DAVID 
 
U-PRICHARD 
DIRECTOR
CYCLACEL PHARMACEUTICALS, INC.   |  ORCA PHARMACEUTICALS, LLC   |  DUAL THERAPEUTICS, LLC   |  VALA SCIENCES INC.   |  ARIX BIOSCIENCE PLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-04-04
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-20 
2017-03-13
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-22 
2017-03-09
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
JEFFRIES + COMPANY, INC.
2347
JEFFRIES INTERNATIONAL LIMITED
NONE
STIFEL, NICOLAUS + COMPANY, INCORPORATED
793
STIFEL NICOLAUS EUROPE LIMITED
NONE
NONE
NONE
LIFESCI CAPITAL LLC
168404
NONE
NONE
JEFFERIES INTERNATIONAL LIMITED
NONE